The goal of this project is to better understand underlying disease mechanisms of Retinitis Pigmentosa (RP), one of the most common forms of inherited retinal degeneration that affects an estimated 100,000 people in the United States alone. To accomplish this, functional studies will be performed for REEP6, a novel RP disease gene that is recently identified. In parallel, additional genes associated with RP will be identified by further characterizing a large cohort of 1,500 RP patients we have recruited during last funding cycle. Through establishing and follow up functional studies of mice model for these newly RP associated disease gene, we expect to gain new insights of disease mechanisms as well as lay the foundation for developing new diagnosis and treatment methods. Mutations in known RP genes account for about 60% of all cases in the European population, suggesting that many additional RP genes remain to be identified. To identify additional RP disease genes, we have collected more than 1,500 patient families from around the world. Screen for mutations in known arRP disease genes suggests that about 600 of these families are likely to carry mutations in novel RP disease genes. Therefore, this collection represents a well characterized, rich resource for identifying new genes that can cause RP. Indeed, whole exome sequencing of a subset of these 600 proband have led the discovery of ten novel disease genes, including the recently identified REEP6 gene. In this proposal, we plan to identify the underlying mutations the remaining proband and newly recruited patients using a combination of whole exome sequencing, bioinformatics, statistics, and functional studies. In parallel, we will conduct functional studies of the newly establish Reep6 knock out and knock in mice to reveal novel interesting underlying disease mechanisms.
Our Specific Aims are to:
Specific Aim 1. Characterize the mechanism of action of the novel RP disease gene REEP6 Specific Aim 2. Identify and characterize novel RP candidate disease genes Specific Aim 3. Investigate noncoding mutations in RP patients Discovery and characterization of novel RP genes will assist the development of new diagnostic tools and treatments. In addition, since mutations in RP disease genes also cause other retinal dystrophies, functional studies of additional RP disease genes will provide important insights into the molecular mechanisms underlying both RP and retinal dystrophies in general.

Public Health Relevance

Description The goal of this research project is to identify and perform functional studies of novel genes that are involved in Retinitis Pigmentosa (RP). As one of the most common forms of inherited retinal degeneration that affects an estimated 100,000 people in the United States alone. Due to the genetic and clinical heterogeneity of the disease, identifying and understanding the molecular basis of the disease is the essential first step for accurate diagnosis as well as developing new treatment methods for the disease.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY022356-08
Application #
9910405
Study Section
Diseases and Pathophysiology of the Visual System Study Section (DPVS)
Program Officer
Shen, Grace L
Project Start
2012-06-01
Project End
2023-03-31
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
8
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Genetics
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
DuPont, Mariana; Jones, Evan M; Xu, Mingchu et al. (2018) Investigating the disease association of USH2A p.C759F variant by leveraging large retinitis pigmentosa cohort data. Ophthalmic Genet 39:291-292
Wang, Jun; Zhao, Li; Wang, Xia et al. (2018) GRIPT: a novel case-control analysis method for Mendelian disease gene discovery. Genome Biol 19:203
Eblimit, Aiden; Zaneveld, Smriti Agrawal; Liu, Wei et al. (2018) NMNAT1 E257K variant, associated with Leber Congenital Amaurosis (LCA9), causes a mild retinal degeneration phenotype. Exp Eye Res 173:32-43
Li, Huajin; Jones, Evan M; Li, Hui et al. (2018) Clinical and genetic features of eight Chinese autosomal-dominant optic atrophy pedigrees with six novel OPA1 pathogenic variants. Ophthalmic Genet 39:569-576
Zaneveld, Smriti Agrawal; Eblimit, Aiden; Liang, Qingnan et al. (2018) Gene Therapy Rescues Retinal Degeneration in Receptor Expression-Enhancing Protein 6 Mutant Mice. Hum Gene Ther :
Dharmat, Rachayata; Eblimit, Aiden; Robichaux, Michael A et al. (2018) SPATA7 maintains a novel photoreceptor-specific zone in the distal connecting cilium. J Cell Biol 217:2851-2865
Gui, Shupeng; Rice, Andrew P; Chen, Rui et al. (2017) A scalable algorithm for structure identification of complex gene regulatory network from temporal expression data. BMC Bioinformatics 18:74
Chen, Yong; Zhao, Li; Wang, Yi et al. (2017) SeqCNV: a novel method for identification of copy number variations in targeted next-generation sequencing data. BMC Bioinformatics 18:147
Agrawal, Smriti A; Burgoyne, Thomas; Eblimit, Aiden et al. (2017) REEP6 deficiency leads to retinal degeneration through disruption of ER homeostasis and protein trafficking. Hum Mol Genet 26:2667-2677
Xu, Mingchu; Xie, Yajing Angela; Abouzeid, Hana et al. (2017) Mutations in the Spliceosome Component CWC27 Cause Retinal Degeneration with or without Additional Developmental Anomalies. Am J Hum Genet 100:592-604

Showing the most recent 10 out of 43 publications